Insider · CIK 0001867470

Northpond Ventures GP, LLC

Reports to the SEC for 5 companies · BETHESDA, MD

sec.gov

Transactions

Companies

Filings

CIK

0001867470

Forms 4 and 5

Insider transactions

20 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2023-06-22	DICE Therapeutics, Inc.S Sale	10% Owner	SSale	−524K sh	$46.50	−$24.3M	166,293
2023-06-22	DICE Therapeutics, Inc.S Sale	10% Owner	SSale	−1.97M sh	$46.50	−$91.6M	633,707
2023-06-05	Telesis Bio Inc.Short-Term WarrantsA Award	Director, 10% Owner	AAward	+1.69M sh	—	—	1,692,549
2023-06-05	Telesis Bio Inc.Redeemable Convertible Preferred StockA Award	Director, 10% Owner	AAward	+80K sh	$100.00	+$8M	3,385,097
2023-06-05	Telesis Bio Inc.Long-Term WarrantsA Award	Director, 10% Owner	AAward	+3.39M sh	—	—	3,385,097
2022-01-11	Vigil Neuroscience, Inc.P Purchase	10% Owner	PPurchase	+355K sh	$14.00	+$4.97M	1,382,978
2022-01-11	Vigil Neuroscience, Inc.Series A Preferred StockC Conversion	10% Owner	CConversion	−2.83M sh	—	—	0
2022-01-11	Vigil Neuroscience, Inc.Series B Preferred StockC Conversion	10% Owner	CConversion	−1.03M sh	—	—	0
2022-01-11	Vigil Neuroscience, Inc.C Conversion	10% Owner	CConversion	+1.03M sh	—	—	1,027,978
2022-01-11	Vigil Neuroscience, Inc.C Conversion	10% Owner	CConversion	+2.83M sh	—	—	2,831,520
2021-09-17	DICE Therapeutics, Inc.Series C Convertible Preferred StockC Conversion	10% Owner	CConversion	−868K sh	—	—	0
2021-09-17	DICE Therapeutics, Inc.Series C-1 Convertible Preferred StockC Conversion	10% Owner	CConversion	−455K sh	—	—	0
2021-09-17	DICE Therapeutics, Inc.C Conversion	10% Owner	CConversion	+2.6M sh	—	—	2,603,075
2021-09-17	DICE Therapeutics, Inc.C Conversion	10% Owner	CConversion	+455K sh	—	—	3,057,871
2021-09-17	DICE Therapeutics, Inc.P Purchase	10% Owner	PPurchase	+235K sh	$17.00	+$4M	3,292,871
2021-09-17	DICE Therapeutics, Inc.Series B Convertible Preferred StockC Conversion	10% Owner	CConversion	−1.74M sh	—	—	0
2021-06-22	Telesis Bio Inc.P Purchase	Director, 10% Owner	PPurchase	+469K sh	$16.00	+$7.5M	9,844,130
2021-06-22	Telesis Bio Inc.Series A-1 Preferred StockC Conversion	Director, 10% Owner	CConversion	−4.16M sh	—	—	0
2021-06-22	Telesis Bio Inc.C Conversion	Director, 10% Owner	CConversion	+9.38M sh	—	—	9,375,380
2021-06-22	Telesis Bio Inc.Series A Preferred StockC Conversion	Director, 10% Owner	CConversion	−5.21M sh	—	—	0

Recent filings

Accepted (ET)
Jun 234
Northpond Ventures, LP0000899243-23-016413
SEC(opens sec.gov)
Jun 74
Northpond Ventures GP, LLC0001104659-23-068998
SEC(opens sec.gov)
Jan 114
Northpond Ventures, LP0000899243-22-001631
SEC(opens sec.gov)
Sep 204
Northpond Ventures, LP0000899243-21-036646
SEC(opens sec.gov)
Jun 244
Northpond Ventures, LP0000899243-21-025745
SEC(opens sec.gov)

Companies

Address

7500 OLD GEORGETOWN ROAD SUITE 850

BETHESDA, MD, 20814